Annual report pursuant to Section 13 and 15(d)

Consolidated Statement of Stockholders' Equity (Deficit)

v3.20.4
Consolidated Statement of Stockholders' Equity (Deficit) - USD ($)
Total
Common Stock
Series A Preferred Stock
Additional Paid-in Capital
Accumulated Deficit
Beginning balance at Dec. 31, 2018 $ (15,422,443) $ 58,271 $ 0 $ 126,076,782 $ (141,557,496)
Beginning balance (in shares) at Dec. 31, 2018   58,270,934 0    
Issuance of common stock 5,928,235 $ 7,184   5,921,051  
Issuance of common stock (in shares)   7,183,488      
Stock options and warrants exercised, and vesting of restricted shares 35,306 $ 630   34,676  
Stock options and warrants exercised and vesting of restricted shares (in shares)   630,141      
Reclassification of warrants to equity 857,072     857,072  
Deemed dividend 0 $ 116   86,091 (86,207)
Deemed dividend (in shares)   116,496      
Value of warrants issued with Series B Preferred Stock 6,709,961 $ 0   6,709,961  
Value of warrants issued with Series B Preferred Stock (in shares)   0      
Value of warrants issued with convertible notes 430,000     430,000  
Common stock issued for preferred stock dividends 1,166,771 $ 719   1,166,052  
Common stock issued for preferred stock dividend (in shares)   718,755      
Conversion of convertible notes 564,817 $ 185   564,632  
Conversion of convertible notes (in shares)   185,186      
Stock-based compensation 1,979,998     1,979,998  
Net income (37,162,827)       (37,162,827)
Ending balance at Dec. 31, 2019 (34,913,110) $ 67,105 $ 0 143,826,315 (178,806,530)
Ending balance (in shares) at Dec. 31, 2019   67,105,000 0    
Stock options and warrants exercised, and vesting of restricted shares 82,093,632 $ 33,933   82,059,699  
Stock options and warrants exercised and vesting of restricted shares (in shares)   33,932,827      
Common stock issued for preferred stock dividends 1,491,860 $ 922   1,490,938  
Common stock issued for preferred stock dividend (in shares)   920,901      
Conversion of convertible notes $ 270,794,684 $ 19,605   270,775,079  
Conversion of convertible notes (in shares) 19,600,000 19,605,013      
Common stock issued for interest on convertible notes $ 1,939,964 $ 358   1,939,606  
Common stock issued for interest on convertible notes (in shares)   358,791      
Stock-based compensation 4,020,805     4,020,805  
Net income 69,776,499       69,776,499
Ending balance at Dec. 31, 2020 $ 395,204,334 $ 121,923 $ 0 $ 504,112,442 $ (109,030,031)
Ending balance (in shares) at Dec. 31, 2020   121,922,532 0